Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Postoperative chemotherapy in rectal carcinoma].

L Cionini1, A Falcone

  • 1U.O. Radioterapia, Dipartimento di Oncologia, UniversitàPisa. cionini@rt.do.med.unipi.it

Annali Italiani Di Chirurgia
|April 27, 2002
PubMed
Summary

Adjuvant chemotherapy may benefit rectal cancer patients with pathological stage B2 or C after preoperative chemoradiation. Further research is needed to clarify chemotherapy

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for a Hidden Sector Scalar from Kaon Decay in the Dimuon Final State at ICARUS.

Physical review letters·2025
Same author

Open abdomen versus primary closure in the management of severe abdominal sepsis: What is the right way? Results of the last 5 years of a reference center.

Langenbeck's archives of surgery·2025
Same author

Comparison of "IN-REC-SUR-E" and LISA in preterm neonates with respiratory distress syndrome: a randomized controlled trial (IN-REC-LISA trial).

Trials·2024
Same author

Comparison of dosimetry with magnetic resonance and computed tomography imaging delineation of surgical bed volume in breast cancer irradiation.

Cancer pathogenesis and therapy·2024
Same author

ICARUS at the Fermilab Short-Baseline Neutrino program: initial operation.

The European physical journal. C, Particles and fields·2023
Same author

Pooled safety analysis from phase III studies of trifluridine/tipiracil in patients with metastatic gastric or gastroesophageal junction cancer and metastatic colorectal cancer.

ESMO open·2022

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastrointestinal Oncology

Context:

  • Rectal carcinoma management requires strategies for local control and preventing distant metastases.
  • Concurrent chemoradiation is the standard adjuvant treatment for pT3 or node-positive rectal carcinomas (NCI Consensus Conference, 1990).
  • The precise role of adjuvant chemotherapy post-surgery, even after preoperative chemoradiation, remains debated.

Purpose:

  • To review and present literature data on the role of adjuvant chemotherapy in rectal cancer.
  • To discuss optimal chemotherapeutic agents and the potential use of chemotherapy alone in low-risk cases.
  • To evaluate the benefit of adjuvant chemotherapy in patients with pathological stage B2 or C disease following preoperative chemoradiation.

Summary:

  • Literature review indicates that adjuvant chemotherapy should likely be administered to rectal cancer patients with pathological stage B2 or C after preoperative chemoradiation.
  • Despite existing data, clear guidelines for adjuvant chemotherapy use, drug selection, and its role in low-risk patients are still lacking.
  • The analysis synthesizes current evidence to inform clinical decision-making regarding adjuvant chemotherapy in rectal cancer treatment.

Impact:

  • Provides insights into optimizing adjuvant treatment strategies for rectal cancer.
  • Highlights areas requiring further investigation to establish definitive guidelines for chemotherapy use.
  • Aims to improve patient outcomes by clarifying the role of adjuvant chemotherapy in specific pathological stages.

Related Experiment Videos